[Nephropathy and hypertension in type II diabetes]

Area of Science:

• Nephrology
• Diabetology
• Cardiovascular Medicine

Context:

• Diabetic nephropathy is the primary cause of uremia and renal replacement therapy in Germany.
• Hypertension is a critical, therapeutically targetable factor in established diabetic nephropathy.
• Understanding pathogenetic mechanisms is crucial for effective antihypertensive therapy.

Purpose:

• To analyze the interaction between hypertension and diabetic nephropathy.
• To discuss pathogenetic mechanisms impacting antihypertensive therapy.
• To highlight the importance of preventive measures for diabetic nephropathy.

Summary:

• Diabetic nephropathy in type II diabetes is the leading cause of end-stage renal failure in Germany.
• Near-normal glycemia and antihypertensive treatment significantly slow renal failure progression.
• Early detection through microalbuminuria testing is essential.

Impact:

• Aggressive blood pressure reduction to normotensive levels is recommended.
• Dietary salt restriction and antihypertensive drug therapy are key interventions.
• Effective management can prevent or delay the progression of diabetic nephropathy.